The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $65.7 M | -73.23% |
2023 | $0.24 B | -52.05% |
2022 | $0.51 B | 157.37% |
2021 | $0.19 B | 22.68% |
2020 | $0.16 B | 98.48% |
2019 | $81.68 M | -82.11% |
2018 | $0.45 B | 188.65% |
2017 | $0.15 B | -34.3% |
2016 | $0.24 B | -7.34% |
2015 | $0.25 B | 105.33% |
2014 | $0.12 B | 171.37% |
2013 | $46.63 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Johnson & Johnson JNJ | $0.14 B | $0.60 B | ๐บ๐ธ USA |
Pfizer PFE | $31.87 M | $0.32 B | ๐บ๐ธ USA |
AbbVie ABBV | $8.76 M | $0.15 B | ๐บ๐ธ USA |
Eli Lilly LLY | $50.92 M | $0.12 B | ๐บ๐ธ USA |
Biogen BIIB | $17.8 M | $72.14 M | ๐บ๐ธ USA |
Gilead Sciences GILD | $49.76 M | $0.27 B | ๐บ๐ธ USA |
Illumina ILMN | $1.26 M | $0.10 B | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $15.53 M | $26.02 M | ๐ฌ๐ง UK |